Profil
Sarah Ankri is currently the Director at France Biotech Association since 2014.
Prior to this, she worked as the Chief Financial Officer at Théraclion SA from 2013 to 2014 and as the Vice President-Finance at Lysogene SA. She also worked as a Manager-Financial Audit at Ernst & Young Audit SAS (France).
Ms. Ankri completed her undergraduate degree from Institut National Agronomique Paris-Grignon.
Postes actifs de Sarah Ankri
| Sociétés | Poste | Début |
|---|---|---|
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry | Directeur/Membre du Conseil | 12/06/2014 |
Anciens postes connus de Sarah Ankri
| Sociétés | Poste | Fin |
|---|---|---|
Ernst & Young Audit SAS (France)
Ernst & Young Audit SAS (France) Miscellaneous Commercial ServicesCommercial Services Provides Auditing & Accounting Services | Comptroller/Controller/Auditor | - |
| LYSOGENE | Directeur Financier/CFO | - |
| THERACLION | Directeur Financier/CFO | - |
Formation de Sarah Ankri
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Institut National Agronomique Paris-Grignon
Institut National Agronomique Paris-Grignon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young Audit SAS (France)
Ernst & Young Audit SAS (France) Miscellaneous Commercial ServicesCommercial Services Provides Auditing & Accounting Services | Commercial Services |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry | Commercial Services |
Théraclion SA
Théraclion SA Medical SpecialtiesHealth Technology Manufactures and markets utlra sound medical products | Health Technology |
Lysogene SA
Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
















